IPSEF - Eton sells ex-U.S. rights for hormone disorder therapy to Esteve Pharma
2025-04-01 12:18:53 ET
More on Eton Pharmaceuticals
- Eton Pharmaceuticals, Inc. (ETON) Virtual Investor Day and Q4 2024 Earnings Call Transcript
- Eton Pharmaceuticals receives new U.S. patent for ET-600
- FDA extends target action date for Eton's ET-400
- Seeking Alpha’s Quant Rating on Eton Pharmaceuticals
- Historical earnings data for Eton Pharmaceuticals